A cross-sectional study was conducted to estimate the prevalence of clinical lameness in high-producing Holstein cows housed in 50 freestall barns in Minnesota during summer. Locomotion and body condition scoring were performed on a total of 5,626 cows in 53 high-production groups. Cow records were collected from the nearest Dairy Herd Improvement Association test date, and herd characteristics were collected at the time of the visit. The mean prevalence of clinical lameness (proportion of cows with locomotion score >or=3 on a 1-to-5 scale, where 1 = normal and 5 = severely lame), and its association with lactation number, month of lactation, body condition score, and type of stall surface were evaluated. The mean prevalence of clinical lameness was 24.6%, which was 3.1 times greater, on average, than the prevalence estimated by the herd managers on each farm. The prevalence of lameness in first-lactation cows was 12.8% and prevalence increased on average at a rate of 8 percentage units per lactation. There was no association between the mean prevalence of clinical lameness and month of lactation (for months 1 to 10). Underconditioned cows had a higher prevalence of clinical lameness than normal or overconditioned cows. The prevalence of lameness was lower in freestall herds with sand stalls (17.1%) than in freestall herds with mattress stall surfaces (27.9%). Data indicate that the best 10th percentile of dairy farms had a mean prevalence of lameness of 5.4% with only 1.47% of cows with locomotion score = 4 and no cows with locomotion score = 5.

The objective of this study was to investigate the association of some herd-level factors with the prevalence of lameness in 53 high-production groups of Holstein cows housed on 50 commercial dairy farms having freestall barns in Minnesota. Cows in the high-production group (n = 5,626) were scored for locomotion (score of 1 to 5, where 1 = normal and 5 = severely lame) to estimate prevalence of lameness (locomotion score >or=3) in the group. Herd-level variables were used to explain the variation in prevalence among groups. Among the variables tested, herd size, pen space per cow, type and size of milking parlor, total mixed ration content of crude protein and neutral detergent fiber, feeding frequency, linear feedbunk space per cow, type of feed barrier, and use of footbath did not show any association with the prevalence of lameness in the univariate analysis screening test and were not included in the multivariate model. Pen stocking density (cows per 100 stalls), total daily distance between pen and milking parlor, number of cows per full-time employee equivalent, cud chewing index, and pen type were eliminated from the multivariate model in the backwards stepwise procedure. Daily time away from the pen for milking was positively associated with the prevalence of lameness, whereas cow comfort quotient was negatively associated with prevalence of lameness. Prevalence of lameness was greater when farms performed hoof trimming only when the manager decided cows needed it because of hoof overgrowth or lameness compared with farms on which the feet of all cows were trimmed on a maintenance schedule once or twice annually. Brisket board height of more than 15.24 cm and presence of the area behind the brisket board filled with concrete were associated with greater prevalence of lameness. Most of these herd-level factors could be managed to reduce lameness prevalence in commercial dairy farms.

A household survey in 1991, at the onset of the Latin American cholera epidemic, investigated high attack rates in Trujillo, Peru, and determined the association between blood group O and severe cholera. Of 463 persons in 69 households, 173 (37%) reported diarrhea, 21% required rehydration therapy, and 4% were hospitalized; these treatment requirements greatly exceeded estimates based on other populations. Elevated vibriocidal or antitoxic antibody titers were present in 52% of 321 from whom serum was obtained; 73% were blood group O. Blood group O was strongly associated with severe cholera: Infected persons had more diarrheal stools per day than persons of other blood groups, were more likely to report vomiting and muscle cramps, and were almost eight times more likely to require hospital treatment. Since prevalence of blood group O in Latin America may be the world's highest, estimates of treatment requirements should be increased to prevent unnecessary deaths.

Decaffeinated GTE was not associated with reductions in body weight, BMI, or WC and did not alter energy intake or mean hormone concentrations in healthy postmenopausal women over 12 mo. GTE decreased fasting insulin concentrations in those with elevated baseline fasting concentrations. The high-activity form of the COMT enzyme may be associated with elevations in insulin and a reduction in adiponectin concentrations over time. This trial was registered at http://www.clinicaltrials.gov as NCT00917735.